CACaption Management, LLC
Institutional investor · Portfolio as of Q3 2021
Top Holdings1,457 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
META PLATFORMS INC-CLASS A | 594,300 | $201.7M | 2.3% | — | — | — | Increased — |
RIO TINTO PLC-SPON ADR | 1.9M | $125.1M | 1.4% | — | — | — | Increased — |
TESLA INC | 150,000 | $116.3M | 1.3% | — | — | — | New — |
LAS VEGAS SANDS CORP | 2.6M | $93.6M | 1.1% | — | — | — | Increased — |
BIOGEN IDEC INC | 309,200 | $87.5M | 1.0% | — | — | — | Increased — |
HEALTH CARE SELECT SECTOR SPDR | 650,000 | $82.7M | 0.9% | — | — | — | New — |
CARVANA CO | 252,600 | $76.2M | 0.9% | — | — | — | Decreased — |
CHARTER COMMUNICATIONS INC - CLASS A | 102,500 | $74.6M | 0.9% | — | — | — | New — |
BIOGEN IDEC INC | 223,300 | $63.2M | 0.7% | $308.49 | -8.26% | 3 qtrssince 2021-Q1 | Increased 53 |
BIOGEN IDEC INC | 210,900 | $59.7M | 0.7% | — | — | — | Increased — |
| 200,000 | $56.3M | 0.6% | — | — | — | New — | |
ASTRAZENECA PLC | 880,800 | $52.9M | 0.6% | — | — | — | Increased — |
ENPHASE ENERGY INC | 352,300 | $52.8M | 0.6% | — | — | — | Decreased — |
CARVANA CO | 175,000 | $52.8M | 0.6% | — | — | — | Unchanged — |
PHILIP MORRIS INTERNATIONAL | 540,000 | $51.2M | 0.6% | — | — | — | New — |
ZILLOW GROUP INC - C | 550,000 | $48.5M | 0.6% | — | — | — | New — |
ADIENT PLC | 1.1M | $46.6M | 0.5% | — | — | — | Decreased — |
ARK INNOVATION ETF | 417,000 | $46.1M | 0.5% | — | — | — | New — |
STAMPS COM INC | 137,500 | $45.3M | 0.5% | — | — | — | New — |
HORIZON THERAPEUTICS PLC | 407,300 | $44.6M | 0.5% | — | — | — | Increased — |
Caption Management, LLC manages $8.7B across 1457 positions as of Q3 2021. Top holdings: META (2.3%), RIO (1.4%), TSLA (1.3%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 294 new positions, 175 exits, 109 increased. Top move: BIIB (INCREASED, conviction 53). Portfolio: $8.7B across 1457 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer